-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on Amgen, Raises Price Target to $515

Benzinga·11/12/2026 13:46:28
Listen to the news
Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $460 to $515.